1. Whole genome sequencing delineates regulatory and novel genic variants in childhood cardiomyopathy
- Author
-
Kaia Mattioli, Lynn Bergin, Bhooma Thiruvahindrapuram, Wilson W L Sung, Anastasia Miron, Jane Lougheed, Ramil R. Noche, Philipp G. Maass, Tapas Mondal, Winona Oliveros, Oyediran Akinrinade, Fintan McKenna, Marta Melé, Stephen W. Scherer, Robert Lesurf, Seema Mital, Jeroen Breckpot, John Smythe, Qian Yang, Abdelrahman Said, Roderick Yao, Ting Liu, Michelle Chan Seng Yue, Erwin Oechslin, James Ellis, Guoliang Meng, and Kathleen Delfosse
- Subjects
Whole genome sequencing ,Genetics ,DSC2 ,Genetic disorder ,Promoter ,Biology ,medicine.disease ,carbohydrates (lipids) ,chemistry.chemical_compound ,chemistry ,Gene expression ,medicine ,Enhancer ,Gene ,DNA - Abstract
Cardiomyopathy (CMP) is a heritable genetic disorder. Protein-coding variants account for 20-30% of cases. The contribution of variants in non-coding DNA elements that regulate gene expression has not been explored. We performed whole-genome sequencing (WGS) of 228 unrelated CMP families. Besides pathogenic protein-coding variants in known CMP genes, 5% cases harbored rare loss-of-function variants in novel cardiac genes, with NRAP and FHOD3 being strong candidates. WGS also revealed a high burden of high-risk variants in promoters and enhancers of CMP genes in an additional 20% cases (Odds ratio 2.14, 95% CI 1.60-2.86, p=5.26×10−7 vs 1326 controls) with genes involved in α-dystroglycan glycosylation (FKTN, DTNA) and desmosomal signaling (DSC2, DSG2) specifically enriched for regulatory variants (False discovery rate
- Published
- 2020
- Full Text
- View/download PDF